Atlas Trials

Determination of the Minimal Concentration of Antifibrinolytics Required to Inhibit t-PA-activated Fibrinolysis

Clinical trial NCT02352675 · COMPLETED

Trial details

NCT number
NCT02352675
Sponsor
Boston Children's Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Congenital Heart DiseaseFibrinolysisRotational Thromboelastometry
Start date
2015-04-01
Primary completion
2016-03-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.